Trials / Completed
CompletedNCT00042224
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
ECT in Clozapine Refractory Schizophrenia
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate electroconvulsive therapy (ECT) in patients who have not responded adequately to clozapine.
Detailed description
ECT augmentation of clozapine will be compared to clozapine monotherapy in schizophrenic patients who continue to have psychotic symptoms despite optimal treatment with clozapine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Electroconvulsive Therapy (ECT) | ECT will be used to augment clozapine in schizophrenic patients who continue to have psychotic symptoms despite optimal treatment with clozapine. |
| DRUG | Clozapine | Patients with psychotic symptoms will receive clozapine |
Timeline
- Start date
- 2000-12-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2002-07-26
- Last updated
- 2017-05-15
- Results posted
- 2015-10-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00042224. Inclusion in this directory is not an endorsement.